Transform Rare Disease Treatment Through AI Innovation

With 35% of infant deaths and 30% of early childhood deaths attributed to rare diseases, there is no time to waste.

Rare diseases affect over 300 million people worldwide—yet only 5% of these conditions have FDA-approved treatments. For those seeking answers, the journey is often long and painful.

Rare disease patients face three critical challenges:

• Delayed or incorrect diagnosis (2-3 misdiagnoses before finding answers)
• Prohibitively expensive drug development (costing up to $2 billion and 14 years per treatment)
• Limited access to advanced computational tools that could accelerate treatment discovery

Every day without proper diagnosis and treatment puts more lives at risk.  But thanks to donors like you, there’s hope. Your support can help us bridge the gap between cutting-edge AI technology and the families who desperately need solutions.

Together, with your impact and our AI-Powered hope, we can:

• Accelerate the development of our AI diagnostic tools
• Expand access to personalized treatment options
• Support research into new therapeutic approaches
• Make advanced genetic analysis more affordable for families in need

RareAI Institute is recognized by the IRS as a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code (EIN: 88-2336284)

To learn more, visit our website.
Become a corporate partner.